-
ClouDr Receives NMPA Green Light for ClouDT-01, a Groundbreaking Digital Diabetes Treatment
•
Hangzhou Kang Ming Information Technology Co., Ltd, trading under the banner of “ClouDr” on the Hong Kong stock exchange (HKG: 9955), has announced that it has secured marketing approval from the National Medical Products Administration (NMPA) for its innovative digital medicine product, ClouDT-01, designed for the treatment of diabetes. Leveraging…
-
ClouDr Partners with Hong Kong Magicure Medical Center to Enhance Cross-Border Medical Access
•
Hangzhou Kang Ming Information Technology Co., Ltd, known as “ClouDr” (HKG: 9955), has entered into a partnership with Hong Kong Magicure Medical Center with the goal of streamlining the supply chain and accelerating domestic access to the world’s leading medical resources in China. This collaboration aims to provide patients with…
